Circulating methylated Septin 9 nucleic acid in the plasma of patients with gastrointestinal cancer in the stomach and colon

Translational Oncology

Volumn 6, Issue 3, 2013, Pages 290-296

  Lee, Hye Seung ^a   Hwang, Sang Mee ^b   Kim, Taek Soo ^a,b   Kim, Duck Woo ^a   Park, Do Joong ^a   Kang, Sung Bum ^a   Kim, Hyung Ho ^a   Park, Kyoung Un ^a,b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; SEPTIN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; TUMOR INVASION; TUMOR VOLUME;

EID: 84878695700     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.13118     Document Type: Article

References (31)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, and Forman D (2011). Global cancer statistics. CA Cancer J Clin 61, 69-90.
2. Hewitson P, Glasziou P, Watson E, Towler B, and Irwig L (2008). Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 103, 1541-1549.
3. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, and Rabeneck L (2009). Association of colonoscopy and death from colorectal cancer. Ann Intern Med 150, 1-8.
4. Qaseem A, Denberg TD, Hopkins RH Jr, Humphrey LL, Levine J, Sweet DE, and Shekelle P (2012). Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med 156, 378-386.
5. Lee BI, Hong SP, Kim SE, Kim SH, Kim HS, Hong SN, Yang DH, Shin SJ, Lee SH, Park DI, et al. (2012). Korean guidelines for colorectal cancer screening and polyp detection. Clin Endosc 45, 25-43.
6. Center MM, Jemal A, Smith RA, and Ward E (2009). Worldwide variations in colorectal cancer. CA Cancer J Clin 59, 366-378.
7. Walsh JM and Terdiman JP (2003). Colorectal cancer screening: scientific review. JAMA 289, 1288-1296.
8. The Lancet. (2012). New guidance for colorectal cancer screening. Lancet 379, 978.
9. Lee EH, Lee HY, Choi KS, Jun JK, Park EC, and Lee JS (2011). Trends in cancer screening rates among Korean men and women: results from the Korean National Cancer Screening Survey (KNCSS), 2004-2010. Cancer Res Treat 43, 141-147.
10. Frieden TR (2011). Forward: CDC Health Disparities and Inequalities Report-United States, 2011. MMWR Surveill Summ 60, 1-2.
11. Pignone M and Sox HC (2008). Screening guidelines for colorectal cancer: a twice-told tale. Ann Intern Med 149, 680-682.
12. Warren JD, Xiong W, Bunker AM, Vaughn CP, Furtado LV, Roberts WL, Fang JC, Samowitz WS, and Heichman KA (2011). Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med 9, 133.
13. Lofton-Day C, Model F, Devos T, Tetzner R, Distler J, Schuster M, Song X, Lesche R, Liebenberg V, Ebert M, et al. (2008). DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 54, 414-423.
14. deVos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J, Steiger KV, Grutzmann R, Pilarsky C, Habermann JK, et al. (2009). Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem 55, 1337-1346.
15. Grutzmann R, Molnar B, Pilarsky C, Habermann JK, Schlag PM, Saeger HD, Miehlke S, Stolz T, Model F, Roblick UJ, et al. (2008). Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One 3, e3759.
16. Toth K, Galamb O, Spisak S, Wichmann B, Sipos F, Valcz G, Leiszter K, Molnar B, and Tulassay Z (2011). The influence of methylated septin 9 gene on RNA and protein level in colorectal cancer. Pathol Oncol Res 17, 503-509.
17. Hall PA and Russell SE (2004). The pathobiology of the septin gene family. J Pathol 204, 489-505.
18. Wang S, Dorsey TH, Terunuma A, Kittles RA, Ambs S, and Kwabi-Addo B (2012). Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer. PLoS One 7, e37928.
19. He Q, Chen HY, Bai EQ, Luo YX, Fu RJ, He YS, Jiang J, and Wang HQ (2010). Development of a multiplex Methy Light assay for the detection of multigene methylation in human colorectal cancer. Cancer Genet Cytogenet 202, 1-10.
20. Kwabi-Addo B, Wang S, Chung W, Jelinek J, Patierno SR, Wang BD, Andrawis R, Lee NH, Apprey V, Issa JP, et al. (2010). Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men. Clin Cancer Res 16, 3539-3547.
21. Nieminen TT, Shoman S, Eissa S, Peltomaki P, and Abdel-Rahman WM (2012). Distinct genetic and epigenetic signatures of colorectal cancers according to ethnic origin. Cancer Epidemiol Biomarkers Prev 21, 202-211.
22. Bennett KL, Karpenko M, Lin MT, Claus R, Arab K, Dyckhoff G, Plinkert P, Herpel E, Smiraglia D, and Plass C (2008). Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma. Cancer Res 68, 4494-4499.
23. Lee HS, Choi SI, Lee HK, Kim HS, Yang HK, Kang GH, Kim YI, Lee BL, and Kim WH (2002). Distinct clinical features and outcomes of gastric cancers with microsatellite instability. Mod Pathol 15, 632-640.
24. Wu M, Semba S, Oue N, Ikehara N, Yasui W, and Yokozaki H (2004). BRAF/K-ras mutation, microsatellite instability, and promoter hypermethylation of hMLH1/MGMT in human gastric carcinomas. Gastric Cancer 7, 246-253.
25. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, and Trotti A (Eds). (2010). AJCC Cancer Staging Manual (7th ed). Springer, New York, NY. pp. 117-126, 143-164.
26. Bosman FT, Carneiro F, Hruban RH, and Theise ND (2010). In WHO Classification of Tumours of the Digestive System. FT Bosman, ES Jaffe, SR Lakhani, and H Ohgaki (Eds). IARC, Lyon, France. pp. 48-58, 134-146.
27. Lee HS, Lee HE, Park do J, Kim HH, Kim WH, and Park KU (2012). Clinical significance of serum and tissue Dickkopf-1 levels in patients with gastric cancer. Clin Chim Acta 413, 1753-1760.
28. Ahlquist DA, Taylor WR, Mahoney DW, Zou H, Domanico M, Thibodeau SN, Boardman LA, Berger BM, and Lidgard GP (2012). The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia. Clin Gastroenterol Hepatol 10, 272-277.
29. Tänzer M, Balluff B, Distler J, Hale K, Leodolter A, Röcken C, Molnar B, Schmid R, Lofton-Day C, and Schuster T (2010). Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions. PLoS One 5, e9061.
30. Shankar J, Messenberg A, Chan J, Underhill TM, Foster LJ, and Nabi IR (2010). Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells. Cancer Res 70, 3780-3790.
31. Connolly D, Yang Z, Castaldi M, Simmons N, Oktay MH, Coniglio S, Fazzari MJ, Verdier-Pinard P, and Montagna C (2011). Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression. Breast Cancer Res 13, R76.